IBRX Description — ImmunityBio Inc

ImmunityBio is a clinical-stage biotechnology company developing therapies and vaccines that complement, harness, and amplify the immune system to defeat cancers and infectious diseases. Co.'s platforms include: antibody cytokine fusion proteins, which include Anktiva™, a class of biopharmaceuticals that improve the therapeutic potential of cytokines, and promote lymphocyte infiltration at a site of disease, improving immune response; and DNA, RNA, and recombinant protein vaccine technologies, which are for infectious diseases to target key viruses, including coronavirus, and for oncology to deliver tumor-associated antigens, and neoepitopes (expressed only by cancer cells).

Company Name: 
ImmunityBio Inc
Number of ETFs Holding IBRX: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   IBRX Weight   IBRX Amount 
 VTI   0.00%   $4,315,131         
 VB   0.00%   $3,739,901         
 IWM   0.01%   $3,351,857         
 VXF   0.00%   $2,658,391         
 VBK   0.01%   $2,143,796         
 IWO   0.01%   $884,813         
 VHT   0.00%   $746,021         
 PTH   0.27%   $476,741         
 IDNA   0.32%   $461,579         
 VTWO   0.01%   $394,214         
List of all 26 ETFs holding IBRX »
Quotes delayed 20 minutes

Email EnvelopeFree IBRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (4.00 out of 4)
88th percentile
(ranked higher than approx. 88% of all stocks covered)
Based on data provided by Zacks Investment Research via

ETFs Holding IBRX | ImmunityBio Inc | ETF Channel |

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.